are alt flares associated with improved virological clearance? - harry janssen, md, phd
Published 4 years ago • 167 plays • Length 17:17
Download video MP4
Download video MP3
Similar videos
-
17:15
is immunomodulation really needed to cure hbv? | harry janssen, md, phd
-
17:30
how to interpret flares in hbv trials with novel agents | pietro lampertico, md, phd
-
16:39
what is the cure rate with current therapies? | harry janssen, md, phd
-
22:18
why do we need new treatments and what is our definition of cure? | harry janssen, md, phd
-
24:23
new treatment strategies for hepatitis b | harry janssen, md, phd
-
28:56
what’s new in hepatitis b treatment & diagnostics | seng gee lim, mbbs, fracp, frcp, md
-
37:13
easl studio s5e14 - hepatic encephalopathy: underdiagnosed and underestimated
-
4:26
hepatitis b and hepatitis c problem symptoms causes treatment all details | samayam telugu
-
58:38
hepatitis a, b, and c clinical overview -- todd wills, md
-
20:21
looking back to move forward: designing next-gen rnai for best results in hbv | bruce given
-
18:46
are hbcrag, hbv rna and anti-hbc viable biomarkers? - florian van bommel, pd dr. med.
-
14:19
current advances in hbv cure research (english) | massimo levrero, md
-
2:16:29
international workshop on hbv cure 2020 - full livestream | session ii
-
19:35
how does hbv interact with the immune system? | robert thimme, md
-
1:34
is a-fib hereditary? | beaumont heart & vascular center
-
2:15:42
international workshop on hbv cure - session i | 11 november 2020
-
36:23
the treatment effectiveness for chronic hepatitis in pediatric populations | manal el-sayed
-
0:48
is there a genetic component of this disease?
-
15:32
update on hepatitis delta therapy | robert gish md, faasld
-
1:26
targeting α-synuclein & neuroinflammation in parkinson's disease
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
Clip.africa.com - Privacy-policy